Osaic Holdings’s Amicus Therapeutics FOLD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,896
| Closed | -$27.4K | – | 8062 |
|
|
2026
Q1 | $27.4K | Sell |
1,896
-887
| -32% | -$12.7K | ﹤0.01% | 5646 |
|
|
2025
Q4 | $39.6K | Sell |
2,783
-586
| -17% | -$5.76K | ﹤0.01% | 5395 |
|
|
2025
Q3 | $26.4K | Sell |
3,369
-735
| -18% | -$5.23K | ﹤0.01% | 5736 |
|
|
2025
Q2 | $25.1K | Buy |
4,104
+3,358
| +450% | +$21.7K | ﹤0.01% | 5539 |
|
|
2025
Q1 | $6.09K | Sell |
746
-3,524
| -83% | -$32.6K | ﹤0.01% | 6075 |
|
|
2024
Q4 | $40.2K | Sell |
4,270
-243
| -5% | -$2.53K | ﹤0.01% | 4853 |
|
|
2024
Q3 | $48.2K | Sell |
4,513
-7,929
| -64% | -$86.4K | ﹤0.01% | 4775 |
|
|
2024
Q2 | $123K | Sell |
12,442
-3,912
| -24% | -$40.2K | ﹤0.01% | 3970 |
|
|
2024
Q1 | $193K | Sell |
16,354
-27,477
| -63% | -$351K | ﹤0.01% | 3726 |
|
|
2023
Q4 | $622K | Buy |
43,831
+24,301
| +124% | +$276K | ﹤0.01% | 2966 |
|
|
2023
Q3 | $237K | Buy |
19,530
+4,166
| +27% | +$53.7K | ﹤0.01% | 3875 |
|
|
2023
Q2 | $193K | Sell |
15,364
-201
| -1% | -$2.38K | ﹤0.01% | 3916 |
|
|
2023
Q1 | $173K | Buy |
15,565
+1,120
| +8% | +$13.8K | ﹤0.01% | 3985 |
|
|
2022
Q4 | $176K | Buy |
14,445
+4,448
| +44% | +$50.1K | ﹤0.01% | 3963 |
|
|
2022
Q3 | $104K | Buy |
9,997
+379
| +4% | +$4.22K | ﹤0.01% | 4334 |
|
|
2022
Q2 | $103K | Buy |
9,618
+259
| +3% | +$2.13K | ﹤0.01% | 4394 |
|
|
2022
Q1 | $88K | Sell |
9,359
-157
| -2% | -$1.47K | ﹤0.01% | 4681 |
|
|
2021
Q4 | $110K | Buy |
9,516
+2,217
| +30% | +$24.7K | ﹤0.01% | 4511 |
|
|
2021
Q3 | $70K | Sell |
7,299
-1,552
| -18% | -$15.9K | ﹤0.01% | 4835 |
|
|
2021
Q2 | $85K | Sell |
8,851
-2,861
| -24% | -$27.9K | ﹤0.01% | 4621 |
|
|
2021
Q1 | $116K | Buy |
11,712
+8,624
| +279% | +$133K | ﹤0.01% | 4228 |
|
|
2020
Q4 | $71K | Buy |
3,088
+11
| +0.4% | +$225 | ﹤0.01% | 4297 |
|
|
2020
Q3 | $45K | Buy |
3,077
+1,589
| +107% | +$23.2K | ﹤0.01% | 4373 |
|
|
2020
Q2 | $24K | Sell |
1,488
-344
| -19% | -$4.19K | ﹤0.01% | 4686 |
|
|
2020
Q1 | $16K | Buy |
+1,832
| New | +$17.4K | ﹤0.01% | 4752 |
|
Other funds holding FOLD
Osaic Holdings's FOLD Position: Q2 2026 in Review
Osaic Holdings sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 1,896 shares — an estimated $27.4K sold.
Osaic Holdings first reported a position in FOLD in Q1 2020 and held it in 25 quarters. The position peaked at $622K in Q4 2023. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.
- Osaic Holdings reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
- Osaic Holdings sold 1,896 Amicus Therapeutics shares in Q2 2026, an estimated $27.4K.
- Osaic Holdings first reported a position in Amicus Therapeutics in Q1 2020 and held it in 25 quarters.
- Osaic Holdings's Amicus Therapeutics position peaked at $622K in Q4 2023.
- 2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.
Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.